QL-007

QL-007 · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QL-007, covering 2018-07-16 to 2019-11-08. Get the full timeline:

Most recent: Clinical Trial Update: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy [Phase 2]

See pricing